Noun
rituximab (uncountable)
(pharmacology) A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis.
Immunomodulating drugs like Rituxan (rituximab) or stem cell transplant may also be considered to treat such a large MS relapse. Source: Internet
Roche continues: 'Pfizer's recently launched oncology biosimilars - such as Ruxience (rituximab), which launched this quarter - have boosted its revenue and market performance. Source: Internet
Discontinuations due to adverse reactions occurred in 16% of patients treated with the combination of venetoclax and rituximab in the MURANO study. Source: Internet
How is rituximab given (Rituxan)? Source: Internet
Your doctor may not want to give you HUMIRA if you have received RITUXAN® (rituximab) recently. Source: Internet